ACETAMINOPHEN; NAPROXEN SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for acetaminophen; naproxen sodium and what is the scope of patent protection?
Acetaminophen; naproxen sodium
is the generic ingredient in one branded drug marketed by Kenvue Brands and is included in one NDA. Additional information is available in the individual branded drug profile pages.Recent Clinical Trials for ACETAMINOPHEN; NAPROXEN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Johnson & Johnson Consumer Inc. (J&JCI) | Phase 1 |
| Johnson & Johnson Consumer Inc. (J&JCI) | Phase 3 |
| Ciusss de L'Est de l'Île de Montréal | N/A |
US Patents and Regulatory Information for ACETAMINOPHEN; NAPROXEN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kenvue Brands | TYLENOL WITH NAPROXEN | acetaminophen; naproxen sodium | TABLET;ORAL | 219962-001 | Jul 24, 2026 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
